UBS Group
NMRD

UBS Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

UBS Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,926
Closed -$3.05K – 10440
2023
Q4 		$3.05K Buy
13,926
+13,841
+16,284% +$3.31K ﹤0.01% 8015
2023
Q3 		$27 Sell
85
-85
-50% -$59 ﹤0.01% 9090
2023
Q2 		$158 Buy
170
+85
+100% +$61 ﹤0.01% 8438
2023
Q1 		$76 Sell
85
-5,063
-98% -$6.55K ﹤0.01% 9282
2022
Q4 		$8.85K Sell
5,148
-582
-10% -$1.28K ﹤0.01% 8718
2022
Q3 		$12K Buy
5,730
+5,645
+6,641% +$11.3K ﹤0.01% 8216
2022
Q2 		$0 Hold
85
– – ﹤0.01% 11269
2022
Q1 		$0 Sell
85
-924
-92% -$3.86K ﹤0.01% 11180
2021
Q4 		$4K Buy
1,009
+924
+1,087% +$4.97K ﹤0.01% 9578
2021
Q3 		$1K Hold
85
– – ﹤0.01% 9307
2021
Q2 		$1K Sell
85
-513
-86% -$4.9K ﹤0.01% 9228
2021
Q1 		$5K Sell
598
-3,585
-86% -$23.7K ﹤0.01% 8353
2020
Q4 		$16K Buy
+4,183
New +$16.1K ﹤0.01% 7128
2020
Q3 		– Sell
-2,320
Closed -$21K – 8539
2020
Q2 		$21K Sell
2,320
-2,723
-54% -$19.4K ﹤0.01% 6534
2020
Q1 		$30K Buy
+5,043
New +$23.2K ﹤0.01% 6217
2019
Q4 		– Sell
-78
Closed -$1K – 8506
2019
Q3 		$1K Buy
+78
New +$662 ﹤0.01% 7869
2019
Q2 		– Sell
-1,046
Closed -$11K – 8245
2019
Q1 		$11K Buy
1,046
+788
+305% +$8.31K ﹤0.01% 6769
2018
Q4 		$2K Sell
258
-24
-9% -$430 ﹤0.01% 7827
2018
Q3 		$7K Buy
+282
New +$7K ﹤0.01% 7353
2018
Q2 		– Sell
-311
Closed -$14K – 8337
2018
Q1 		$14K Buy
+311
New +$16.5K ﹤0.01% 6676

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group's NMRD Position: Q1 2024 in Review

UBS Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 13,926 shares — an estimated $3.05K sold.

UBS Group first reported a position in NMRD in Q1 2018 and held it in 20 quarters. The position peaked at $30K in Q1 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • UBS Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 13,926 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $3.05K.
  • UBS Group first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 20 quarters.
  • UBS Group's Nemaura Medical, Inc. Common Stock position peaked at $30K in Q1 2020.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.